{"transactions":[{"id":4636977,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-07T20:08:53.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Option is fully vested and exercisable."}],"balance_after":46398,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001813798-26-000023","document":"wk-form4_1791403730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000023/wk-form4_1791403730.xml","form_type":"4"}},{"id":4636976,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-07T20:08:53.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":86.74,"value":1561320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."}],"balance_after":145435,"source":{"system":"sec-edgar","filing":"0001813798-26-000023","document":"wk-form4_1791403730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000023/wk-form4_1791403730.xml","form_type":"4"}},{"id":4636975,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-07T20:08:53.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":5.35,"value":96300.0,"ownership":{"direct":true},"balance_after":163435,"source":{"system":"sec-edgar","filing":"0001813798-26-000023","document":"wk-form4_1791403730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000023/wk-form4_1791403730.xml","form_type":"4"}},{"id":4636972,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-07T20:07:54.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Option is fully vested and exercisable."}],"balance_after":74068,"derivative":{"exercise_price":25.92,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001960048-26-000013","document":"wk-form4_1791403671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000013/wk-form4_1791403671.xml","form_type":"4"}},{"id":4636971,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-10-07T20:07:54.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":19000,"price":86.74,"value":1648060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025."}],"balance_after":27860,"source":{"system":"sec-edgar","filing":"0001960048-26-000013","document":"wk-form4_1791403671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000013/wk-form4_1791403671.xml","form_type":"4"}},{"id":4636970,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-10-07T20:07:54.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":19000,"price":25.92,"value":492480.0,"ownership":{"direct":true},"balance_after":46860,"source":{"system":"sec-edgar","filing":"0001960048-26-000013","document":"wk-form4_1791403671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000013/wk-form4_1791403671.xml","form_type":"4"}},{"id":4632630,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock Option is fully vested and exercisable."}],"balance_after":64398,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4632629,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":95,"price":57.094,"value":5423.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $57.09 to $57.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":145435,"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4632628,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":2155,"price":56.654,"value":122089.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.065 to $56.955. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":145530,"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4632627,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":2250,"price":5.35,"value":12037.5,"ownership":{"direct":true},"balance_after":147685,"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4613718,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-09-09T21:56:09.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":17056,"price":60.36,"value":1029500.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":429902,"source":{"system":"sec-edgar","filing":"0001258693-26-000019","document":"wk-form4_1788990967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000019/wk-form4_1788990967.xml","form_type":"4"}},{"id":4613717,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-09-09T21:54:20.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":7155,"price":60.36,"value":431875.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":95316,"source":{"system":"sec-edgar","filing":"0001230724-26-000018","document":"wk-form4_1788990858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000018/wk-form4_1788990858.xml","form_type":"4"}},{"id":4613715,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1166,"kind":"person","name":"Dhaliwal Harpreet S.","position":1,"cik":"0001886794","reported_name":"Dhaliwal Harpreet S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops Officer"}}],"security":"Common Stock","published_at":"2026-09-09T21:53:10.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":7651,"price":60.36,"value":461814.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":68085,"source":{"system":"sec-edgar","filing":"0001886794-26-000012","document":"wk-form4_1788990788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886794/000188679426000012/wk-form4_1788990788.xml","form_type":"4"}},{"id":4613714,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-09-09T21:52:14.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1327,"price":60.36,"value":80097.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":27860,"source":{"system":"sec-edgar","filing":"0001960048-26-000011","document":"wk-form4_1788990731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000011/wk-form4_1788990731.xml","form_type":"4"}},{"id":4613691,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-09-09T21:46:35.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":1334,"price":59.521,"value":79401.014,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $59.155 to $60.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":145435,"source":{"system":"sec-edgar","filing":"0001813798-26-000019","document":"wk-form4_1788990392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000019/wk-form4_1788990392.xml","form_type":"4"}},{"id":4613690,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-09-09T21:46:35.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":5459,"price":60.36,"value":329505.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":146769,"source":{"system":"sec-edgar","filing":"0001813798-26-000019","document":"wk-form4_1788990392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000019/wk-form4_1788990392.xml","form_type":"4"}},{"id":4613689,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-09-09T21:46:35.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":1381,"price":61.16,"value":84461.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.95 to $61.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":152228,"source":{"system":"sec-edgar","filing":"0001813798-26-000019","document":"wk-form4_1788990392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000019/wk-form4_1788990392.xml","form_type":"4"}},{"id":4613664,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":182681,"kind":"person","name":"Jodar Luis","position":1,"cik":"0002151661","reported_name":"Jodar Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-09T21:40:24.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":88254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option shall vest on August 31, 2027, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":88254,"derivative":{"exercise_price":61.16,"expiration_date":"2036-09-04","underlying":"Common Stock","underlying_shares":88254},"source":{"system":"sec-edgar","filing":"0002151661-26-000004","document":"wk-form4_1788990021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2151661/000215166126000004/wk-form4_1788990021.xml","form_type":"4"}},{"id":4613663,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":182681,"kind":"person","name":"Jodar Luis","position":1,"cik":"0002151661","reported_name":"Jodar Luis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-09T21:40:24.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":52632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as\nto 1/4 of the shares subject to the award on September 7, 2027 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":52632,"source":{"system":"sec-edgar","filing":"0002151661-26-000004","document":"wk-form4_1788990021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2151661/000215166126000004/wk-form4_1788990021.xml","form_type":"4"}},{"id":1443,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Stock Option is fully vested and exercisable."}],"balance_after":66648,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1442,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1432,"price":61.58,"value":88182.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":153609,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1441,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":303,"price":61.424,"value":18611.472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":155041,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1440,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":924,"price":60.955,"value":56322.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":155344,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1439,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":713,"price":61.481,"value":43835.953,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":156268,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1438,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":1537,"price":60.886,"value":93581.782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":156981,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1437,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2250,"price":5.35,"value":12037.5,"ownership":{"direct":true},"balance_after":158518,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1436,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1273,"price":60.74,"value":77322.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":156268,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1435,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:57:33.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3427,"price":61.58,"value":211034.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":446958,"source":{"system":"sec-edgar","filing":"0001258693-26-000017","document":"wk-form4_1788393451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000017/wk-form4_1788393451.xml","form_type":"4"}},{"id":1434,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:57:33.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2862,"price":60.74,"value":173837.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":450385,"source":{"system":"sec-edgar","filing":"0001258693-26-000017","document":"wk-form4_1788393451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000017/wk-form4_1788393451.xml","form_type":"4"}},{"id":1433,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-09-02T23:56:55.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1432,"price":61.58,"value":88182.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":102471,"source":{"system":"sec-edgar","filing":"0001230724-26-000016","document":"wk-form4_1788393412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000016/wk-form4_1788393412.xml","form_type":"4"}},{"id":1432,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-09-02T23:56:55.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1273,"price":60.74,"value":77322.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":103903,"source":{"system":"sec-edgar","filing":"0001230724-26-000016","document":"wk-form4_1788393412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000016/wk-form4_1788393412.xml","form_type":"4"}},{"id":1431,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1166,"kind":"person","name":"Dhaliwal Harpreet S.","position":1,"cik":"0001886794","reported_name":"Dhaliwal Harpreet S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:56:10.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":659,"price":61.58,"value":40581.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":75736,"source":{"system":"sec-edgar","filing":"0001886794-26-000010","document":"wk-form4_1788393367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886794/000188679426000010/wk-form4_1788393367.xml","form_type":"4"}},{"id":1430,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1166,"kind":"person","name":"Dhaliwal Harpreet S.","position":1,"cik":"0001886794","reported_name":"Dhaliwal Harpreet S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:56:10.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":361,"price":60.74,"value":21927.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":76395,"source":{"system":"sec-edgar","filing":"0001886794-26-000010","document":"wk-form4_1788393367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886794/000188679426000010/wk-form4_1788393367.xml","form_type":"4"}},{"id":1429,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-09-02T23:54:51.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":326,"price":61.58,"value":20075.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":29187,"source":{"system":"sec-edgar","filing":"0001960048-26-000009","document":"wk-form4_1788393289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000009/wk-form4_1788393289.xml","form_type":"4"}},{"id":1428,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1165,"kind":"person","name":"Cowan Elvia","position":1,"cik":"0001960048","reported_name":"Cowan Elvia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-09-02T23:54:51.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":243,"price":60.74,"value":14759.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":29513,"source":{"system":"sec-edgar","filing":"0001960048-26-000009","document":"wk-form4_1788393289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960048/000196004826000009/wk-form4_1788393289.xml","form_type":"4"}},{"id":695912,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1166,"kind":"person","name":"Dhaliwal Harpreet S.","position":1,"cik":"0001886794","reported_name":"Dhaliwal Harpreet S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-05T23:01:41.000Z","date":"2026-08-05","kind":"exercise","planned":true,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock Option is fully vested and exercisable."}],"balance_after":28000,"derivative":{"exercise_price":24.79,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001886794-26-000008","document":"wk-form4_1785970896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1886794/000188679426000008/wk-form4_1785970896.xml","form_type":"4"}},{"id":695911,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1166,"kind":"person","name":"Dhaliwal Harpreet S.","position":1,"cik":"0001886794","reported_name":"Dhaliwal Harpreet S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops Officer"}}],"security":"Common Stock","published_at":"2026-08-05T23:01:41.000Z","date":"2026-08-05","kind":"sale","planned":true,"acquired":false,"shares":17000,"price":55.004,"value":935068.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.00 to $55.255. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":76756,"source":{"system":"sec-edgar","filing":"0001886794-26-000008","document":"wk-form4_1785970896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886794/000188679426000008/wk-form4_1785970896.xml","form_type":"4"}},{"id":695910,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1166,"kind":"person","name":"Dhaliwal Harpreet S.","position":1,"cik":"0001886794","reported_name":"Dhaliwal Harpreet S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Ops Officer"}}],"security":"Common Stock","published_at":"2026-08-05T23:01:41.000Z","date":"2026-08-05","kind":"exercise","planned":true,"acquired":true,"shares":17000,"price":24.79,"value":421430.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 780 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":93756,"source":{"system":"sec-edgar","filing":"0001886794-26-000008","document":"wk-form4_1785970896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886794/000188679426000008/wk-form4_1785970896.xml","form_type":"4"}},{"id":696393,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Stock Option is fully vested and exercisable."}],"balance_after":68898,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":696392,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":1389,"price":54.089,"value":75129.621,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.935 to $54.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":157541,"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":696391,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":861,"price":53.502,"value":46065.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $52.915 to $53.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":158930,"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":696390,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":2250,"price":5.35,"value":12037.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":159791,"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":695693,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option is fully vested and exercisable."}],"balance_after":216827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":695692,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":3044,"price":54.178,"value":164917.832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.07 to $54.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":105176,"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":695691,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":6956,"price":53.761,"value":373961.516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.06 to $54.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":108220,"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":695690,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-08-05T20:58:16.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":5.35,"value":53500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":115176,"source":{"system":"sec-edgar","filing":"0001230724-26-000014","document":"wk-form4_1785963491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000014/wk-form4_1785963491.xml","form_type":"4"}},{"id":702193,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"exercise","planned":true,"acquired":false,"shares":16198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Option is fully vested and exercisable."}],"balance_after":137000,"derivative":{"exercise_price":2.03,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":16198},"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702192,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":378,"price":55.914,"value":21135.492,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.82 to $56.085. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":133215,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702191,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":622,"price":55.54,"value":34545.88,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.71. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":133593,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702190,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":244,"price":55.964,"value":13655.216,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.81 to $56.18. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":133215,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702189,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":756,"price":55.516,"value":41970.096,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.71. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":133459,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702188,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":4415,"price":55.931,"value":246935.365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.77 to $56.13. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":453247,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702187,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":11783,"price":55.515,"value":654133.245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.765. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":457662,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":702186,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-07-28T20:10:39.000Z","date":"2026-07-27","kind":"exercise","planned":true,"acquired":true,"shares":16198,"price":2.03,"value":32881.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":469445,"source":{"system":"sec-edgar","filing":"0001258693-26-000015","document":"wk-form4_1785269436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000015/wk-form4_1785269436.xml","form_type":"4"}},{"id":708039,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":30083,"kind":"person","name":"Markels John","position":1,"cik":"0001803424","reported_name":"Markels John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-16T20:56:14.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":23029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shall vest over 36 months, 1/3 of which will vest on July 16, 2027 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":23029,"derivative":{"exercise_price":56.04,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":23029},"source":{"system":"sec-edgar","filing":"0001803424-26-000004","document":"wk-form4_1784235372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000180342426000004/wk-form4_1784235372.xml","form_type":"4"}},{"id":715207,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option is fully vested and exercisable."}],"balance_after":226827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":715206,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":2087,"price":57.764,"value":120553.468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $57.61 to $58.32. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":104395,"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":715205,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":7913,"price":57.157,"value":452283.341,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.595 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":106482,"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":715204,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-07-06T23:31:52.000Z","date":"2026-07-06","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":5.35,"value":53500.0,"ownership":{"direct":true},"balance_after":114395,"source":{"system":"sec-edgar","filing":"0001230724-26-000012","document":"wk-form4_1783380710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000012/wk-form4_1783380710.xml","form_type":"4"}},{"id":716543,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock Option is fully vested and exercisable."}],"balance_after":71148,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":516},"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716542,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":6,"price":57.82,"value":346.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."}],"balance_after":156760,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716541,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":456,"price":57.473,"value":26207.688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.695 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":156766,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716540,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":1788,"price":56.03,"value":100181.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.60 to $56.595. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":157222,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716539,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":516,"price":5.35,"value":2760.6,"ownership":{"direct":true},"balance_after":159010,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":725465,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":191,"price":56.266,"value":10746.806,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.00 to $56.54. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":134215,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725464,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":602,"price":55.297,"value":33288.794,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.72. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":134406,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725463,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":207,"price":54.222,"value":11223.954,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.42. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":135008,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725462,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":332,"price":55.993,"value":18589.676,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.88 to $56.12. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":134215,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725461,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":356,"price":55.226,"value":19660.456,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.51. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":134547,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725460,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":312,"price":54.345,"value":16955.64,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":134903,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725459,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":6417,"price":56.121,"value":360128.457,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.815 to $56.60. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":452466,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725458,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":9137,"price":55.265,"value":504956.305,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $54.755 to $55.73. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":458883,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":725457,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T22:49:13.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":6683,"price":54.275,"value":362719.825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.755 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":468020,"source":{"system":"sec-edgar","filing":"0001258693-26-000013","document":"wk-form4_1782514151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000013/wk-form4_1782514151.xml","form_type":"4"}},{"id":729142,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":35979,"kind":"person","name":"Slaoui Moncef","position":1,"cik":"0001712369","reported_name":"Slaoui Moncef","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-23T20:30:00.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":26061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shall vest over 36 months, 1/3 of which will vest on June 17, 2027 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":26061,"derivative":{"exercise_price":52.11,"expiration_date":"2036-06-22","underlying":"Common Stock","underlying_shares":26061},"source":{"system":"sec-edgar","filing":"0001712369-26-000008","document":"wk-form4_1782246596.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000171236926000008/wk-form4_1782246596.xml","form_type":"4"}},{"id":732078,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":225},"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732077,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":52.5,"value":52500.0,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the benefit of the Reporting Person's daughter."}],"balance_after":135215,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732076,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":52.5,"value":52500.0,"ownership":{"direct":false,"nature":"By Children's Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by a trust for the benefit of the Reporting Person's son."}],"balance_after":135215,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732075,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":22236,"price":52.5,"value":1167390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."}],"balance_after":474703,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732074,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":225,"price":52.51,"value":11814.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."}],"balance_after":496939,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732073,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1168,"kind":"person","name":"PICKERING GRANT","position":1,"cik":"0001258693","reported_name":"PICKERING GRANT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-06-19T00:08:15.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":225,"price":1.79,"value":402.75,"ownership":{"direct":true},"balance_after":497164,"source":{"system":"sec-edgar","filing":"0001258693-26-000010","document":"wk-form4_1781827692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000125869326000010/wk-form4_1781827692.xml","form_type":"4"}},{"id":732072,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-19T00:07:40.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option is fully vested and exercisable."}],"balance_after":236827,"derivative":{"exercise_price":5.35,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001230724-26-000010","document":"wk-form4_1781827658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000010/wk-form4_1781827658.xml","form_type":"4"}},{"id":732071,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-06-19T00:07:40.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":53,"value":530000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026."}],"balance_after":104395,"source":{"system":"sec-edgar","filing":"0001230724-26-000010","document":"wk-form4_1781827658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000010/wk-form4_1781827658.xml","form_type":"4"}},{"id":732070,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CFO"}}],"security":"Common Stock","published_at":"2026-06-19T00:07:40.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":5.35,"value":53500.0,"ownership":{"direct":true},"balance_after":114395,"source":{"system":"sec-edgar","filing":"0001230724-26-000010","document":"wk-form4_1781827658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000123072426000010/wk-form4_1781827658.xml","form_type":"4"}},{"id":736164,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:21:17.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001606244-26-000004","document":"wk-form4_1781641275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160624426000004/wk-form4_1781641275.xml","form_type":"4"}},{"id":736163,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:21:17.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will\nfully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. Pursuant to the Issuer's Nonqualified RSU Deferral Program for Non-Employee Directors, the Reporting Person has deferred delivery of all of such vested RSUs to the earlier of (i) a separation from service, or (ii) a qualifying change in control."}],"balance_after":6856,"source":{"system":"sec-edgar","filing":"0001606244-26-000004","document":"wk-form4_1781641275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160624426000004/wk-form4_1781641275.xml","form_type":"4"}},{"id":736162,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":16580,"kind":"person","name":"BRANDICOURT OLIVIER","position":1,"cik":"0001508518","reported_name":"BRANDICOURT OLIVIER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:20:45.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11034,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11034},"source":{"system":"sec-edgar","filing":"0001508518-26-000005","document":"wk-form4_1781641242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000150851826000005/wk-form4_1781641242.xml","form_type":"4"}},{"id":736161,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":16580,"kind":"person","name":"BRANDICOURT OLIVIER","position":1,"cik":"0001508518","reported_name":"BRANDICOURT OLIVIER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:20:45.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":4699,"source":{"system":"sec-edgar","filing":"0001508518-26-000005","document":"wk-form4_1781641242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000150851826000005/wk-form4_1781641242.xml","form_type":"4"}},{"id":736200,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:20:06.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001691218-26-000002","document":"wk-form4_1781641202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000169121826000002/wk-form4_1781641202.xml","form_type":"4"}},{"id":736199,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:20:06.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":5306,"source":{"system":"sec-edgar","filing":"0001691218-26-000002","document":"wk-form4_1781641202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000169121826000002/wk-form4_1781641202.xml","form_type":"4"}},{"id":736160,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37685,"kind":"person","name":"Lee Jacks","position":1,"cik":"0001935943","reported_name":"Lee Jacks","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:18:43.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001935943-26-000002","document":"wk-form4_1781641121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000193594326000002/wk-form4_1781641121.xml","form_type":"4"}},{"id":736159,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37685,"kind":"person","name":"Lee Jacks","position":1,"cik":"0001935943","reported_name":"Lee Jacks","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:18:43.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":6856,"source":{"system":"sec-edgar","filing":"0001935943-26-000002","document":"wk-form4_1781641121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000193594326000002/wk-form4_1781641121.xml","form_type":"4"}},{"id":736158,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":36260,"kind":"person","name":"Gilbert Halley E","position":1,"cik":"0001601360","reported_name":"Gilbert Halley E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:18:02.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001601360-26-000002","document":"wk-form4_1781641080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160136026000002/wk-form4_1781641080.xml","form_type":"4"}},{"id":736157,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":36260,"kind":"person","name":"Gilbert Halley E","position":1,"cik":"0001601360","reported_name":"Gilbert Halley E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:18:02.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":12481,"source":{"system":"sec-edgar","filing":"0001601360-26-000002","document":"wk-form4_1781641080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160136026000002/wk-form4_1781641080.xml","form_type":"4"}},{"id":736156,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:17:19.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001829111-26-000009","document":"wk-form4_1781641036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000182911126000009/wk-form4_1781641036.xml","form_type":"4"}},{"id":736155,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:17:19.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. Pursuant to the Issuer's Nonqualified RSU Deferral Program for Non-Employee Directors, the Reporting Person has deferred delivery of all of such vested RSUs to the earlier of (i) a separation from service, or (ii) a qualifying change in control ."}],"balance_after":12481,"source":{"system":"sec-edgar","filing":"0001829111-26-000009","document":"wk-form4_1781641036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000182911126000009/wk-form4_1781641036.xml","form_type":"4"}},{"id":736152,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37682,"kind":"person","name":"Drapeau Anne S","position":1,"cik":"0001296569","reported_name":"Drapeau Anne S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:16:35.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001296569-26-000002","document":"wk-form4_1781640992.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000129656926000002/wk-form4_1781640992.xml","form_type":"4"}},{"id":736151,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37682,"kind":"person","name":"Drapeau Anne S","position":1,"cik":"0001296569","reported_name":"Drapeau Anne S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:16:35.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":12481,"source":{"system":"sec-edgar","filing":"0001296569-26-000002","document":"wk-form4_1781640992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000129656926000002/wk-form4_1781640992.xml","form_type":"4"}},{"id":736154,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:15:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001596385-26-000002","document":"wk-form4_1781640912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000159638526000002/wk-form4_1781640912.xml","form_type":"4"}},{"id":736153,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37683,"kind":"person","name":"Lukatch Heath","position":1,"cik":"0001596385","reported_name":"Lukatch Heath","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:15:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":19481,"source":{"system":"sec-edgar","filing":"0001596385-26-000002","document":"wk-form4_1781640912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000159638526000002/wk-form4_1781640912.xml","form_type":"4"}},{"id":753333,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-03T20:59:15.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":301,"price":50.257,"value":15127.357,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $50.205 to $51.01. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":158494,"source":{"system":"sec-edgar","filing":"0001813798-26-000011","document":"wk-form4_1780520351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000011/wk-form4_1780520351.xml","form_type":"4"}}],"next_cursor":"2026-06-03T20:59:15.000000Z,753333"}